Showing results (1641-1650 of 1,799) with videos related to
Sort By:
Pageof 180
Mabs|March 12, 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B Overdijk, Sandra Verploegen, Marijn Bögels, et al.Mabs|August 5, 2020
The Antibody Society's antibody validation webinar seriesJan L A Voskuil, Anita Bandrowski, C Glenn Begley, et al.Mabs|August 31, 2012
Characterization of antibody variants during process development: the tale of incomplete processing of N-terminal secretion peptideAlexandre Ambrogelly, Yan-Hui Liu, Hong Li, et al.Mabs|September 7, 2012
Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic miceVasco Filipe, Wim Jiskoot, Abdul Hafid Basmeleh, et al.Mabs|August 25, 2020
Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous andvirion-associated SERINC5Sebastian Molnar, Lindsay Wieczorek, Michelle Zemil, et al.Mabs|August 20, 2020
Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to Aβ aggregatesAllyson Kwiatkowski, Carl Co, Sei Kameoka, et al.Mabs|March 13, 2015
Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1βSusan E Lacy, Chengbin Wu, Dominic J Ambrosi, et al.Mabs|May 29, 2014
Rituximab: how approval history is reflected by a corresponding patent filing strategyUlrich StorzMabs|July 24, 2012
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningYen Phung, Wei Gao, Yan-Gao Man, et al.Mabs|June 14, 2014
O-glycosylation of glycine-serine linkers in recombinant Fc-fusion proteins: attachment of glycosaminoglycans and other intermediates with phosphorylation at the xylose sugar subunitChris Spahr, Stone D-H Shi, Hsieng S LuPageof 180